DSS, Inc. reported a total revenue of $6.39 million for the third quarter of 2025, marking a 14% increase from $5.60 million in the same period of 2024. For the nine months ending September 30, 2025, revenue rose 22% to $16.63 million compared to $13.68 million in the prior year. The growth was primarily driven by a 16% increase in printed products revenue, which reached $4.99 million, and a significant 45% rise in rental income, totaling $718,000. However, net investment revenue saw a sharp decline of 84%, falling to $7,000, attributed to several loans going into non-accrual status.

The company's operating loss for the third quarter improved to $3.23 million, down from a loss of $4.67 million in the same quarter of 2024, reflecting a 31% reduction. For the nine-month period, the operating loss decreased by 27% to $10.38 million from $14.29 million year-over-year. The overall net loss for the third quarter was $2.23 million, a 61% improvement compared to a net loss of $5.70 million in the prior year. For the nine months, the net loss was $10.09 million, down from $15.76 million in 2024.

DSS, Inc. has made strategic moves, including the sale of its Plano, Texas facility for $9.5 million, which contributed to a net cash inflow from investing activities of $12.08 million for the nine months ended September 30, 2025. The company also reported a significant increase in its cash position, with cash and cash equivalents totaling approximately $7.02 million at the end of the reporting period, down from $11.43 million at the end of 2024. The company’s total liabilities decreased to $66.02 million from $73.74 million, primarily due to the reduction in long-term debt.

Operationally, DSS, Inc. has focused on enhancing its product offerings and expanding its market reach. The company operates across five distinct business lines, including Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The biotechnology segment has begun to see revenue from retail sales, generating $11,000 in the third quarter. The company has also been actively managing its investments, with notable unrealized gains in its marketable securities portfolio.

Looking ahead, DSS, Inc. aims to continue its focus on revenue growth and operational efficiency while navigating the challenges posed by its loan portfolio. The company has expressed confidence in its ability to access capital through equity and debt financing to support its operations and strategic initiatives. However, the ongoing operating losses and cash flow challenges raise concerns about its ability to sustain operations in the long term without further financial restructuring or capital infusion.

About DSS, INC.

DSS, Inc. operates across diverse sectors including product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing. It develops innovative healthcare technologies, provides custom packaging solutions, offers financial services, and manages real estate investments. The company leverages strategic partnerships, patents, and a decentralized growth model to create long-term shareholder value through innovation, operational efficiency, and targeted market expansion.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.